ioversol has been researched along with Kidney Diseases in 23 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The incidence of CIN in patients with multiple myeloma with a normal creatinine level is low and correlates with β(2)-microglobulin levels." | 1.37 | Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. ( Avigan, DE; Kruskal, JB; LeBedis, CA; Pahade, JK; Pedrosa, I; Raptopoulos, VD; Yam, CS, 2011) |
| "We sought to report adverse event (AE) rates attributed to contrast administration in a pediatric cardiac catheterization lab and identify characteristics related to higher doses." | 1.35 | Contrast administration in pediatric cardiac catheterization: dose and adverse events. ( Bergersen, L; Gauvreau, K; Lock, JE; Marshall, AC; Senthilnathan, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, F | 3 |
| Zhang, G | 2 |
| Zhou, Y | 1 |
| Gui, D | 1 |
| Li, J | 2 |
| Xing, T | 2 |
| Wang, N | 2 |
| Zhao, B | 2 |
| Zhao, Q | 2 |
| Zhao, Z | 1 |
| Liao, G | 1 |
| Zhou, Q | 1 |
| Lv, D | 1 |
| Holthfer, H | 1 |
| Zou, H | 1 |
| Yin, J | 1 |
| Lu, Z | 1 |
| Kong, Y | 1 |
| Senthilnathan, S | 1 |
| Gauvreau, K | 1 |
| Marshall, AC | 1 |
| Lock, JE | 1 |
| Bergersen, L | 1 |
| Reed, M | 1 |
| Meier, P | 1 |
| Tamhane, UU | 1 |
| Welch, KB | 1 |
| Moscucci, M | 1 |
| Gurm, HS | 1 |
| Hernández, F | 1 |
| Mora, L | 1 |
| García-Tejada, J | 1 |
| Velázquez, M | 1 |
| Gómez-Blázquez, I | 1 |
| Bastante, T | 1 |
| Albarrán, A | 1 |
| Andreu, J | 1 |
| Tascón, J | 1 |
| Ng, CS | 1 |
| Shaw, AD | 1 |
| Bell, CS | 1 |
| Samuels, JA | 1 |
| Pahade, JK | 1 |
| LeBedis, CA | 1 |
| Raptopoulos, VD | 1 |
| Avigan, DE | 1 |
| Yam, CS | 1 |
| Kruskal, JB | 1 |
| Pedrosa, I | 1 |
| Balemans, CE | 1 |
| Reichert, LJ | 1 |
| van Schelven, BI | 1 |
| van den Brand, JA | 1 |
| Wetzels, JF | 1 |
| Chamsuddin, AA | 1 |
| Kowalik, KJ | 1 |
| Bjarnason, H | 1 |
| Dietz, CA | 1 |
| Rosenberg, MS | 1 |
| Gomes, MD | 1 |
| McDermott, CM | 1 |
| Hunter, DW | 1 |
| Zager, RA | 1 |
| Johnson, AC | 1 |
| Hanson, SY | 1 |
| Yano, T | 1 |
| Itoh, Y | 1 |
| Kubota, T | 1 |
| Sendo, T | 1 |
| Koyama, T | 1 |
| Fujita, T | 1 |
| Saeki, K | 1 |
| Yuo, A | 1 |
| Oishi, R | 1 |
| Niboshi, A | 1 |
| Nishida, M | 1 |
| Itoi, T | 1 |
| Shiraishi, I | 1 |
| Hamaoka, K | 1 |
| Mitsnefes, MM | 1 |
| Kathman, TS | 1 |
| Mishra, J | 1 |
| Kartal, J | 1 |
| Khoury, PR | 1 |
| Nickolas, TL | 1 |
| Barasch, J | 1 |
| Devarajan, P | 2 |
| Hirsch, R | 1 |
| Dent, C | 1 |
| Pfriem, H | 1 |
| Allen, J | 1 |
| Beekman, RH | 1 |
| Ma, Q | 1 |
| Dastrala, S | 1 |
| Bennett, M | 1 |
| Mitsnefes, M | 1 |
| Koncz, PM | 1 |
| Heyman, SN | 1 |
| Clark, BA | 1 |
| Cantley, L | 1 |
| Spokes, K | 1 |
| Rosen, S | 1 |
| Brezis, M | 1 |
| Epstein, FH | 1 |
| Hayami, S | 1 |
| Ishigooka, M | 1 |
| Suzuki, Y | 1 |
| Hashimoto, T | 1 |
| Nakada, T | 1 |
| Mitobe, K | 1 |
| Kini, AS | 1 |
| Mitre, CA | 1 |
| Kamran, M | 1 |
| Suleman, J | 1 |
| Kim, M | 1 |
| Duffy, ME | 1 |
| Marmur, JD | 1 |
| Sharma, SK | 1 |
| Chagnaud, C | 1 |
| Moulin, G | 1 |
| Delannoy, L | 1 |
| Gaubert, JY | 1 |
| Haddad, D | 1 |
| Bartoli, JM | 1 |
| Kasbarian, M | 1 |
| Joffre, F | 1 |
| Rousseau, H | 1 |
| Aziza, R | 1 |
| Montagne, J | 1 |
| Adamsbaum, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chinese People's Liberation Army General Hospital[NCT02718521] | 400 participants (Anticipated) | Interventional | 2016-03-31 | Active, not recruiting | |||
| Chinese People's Liberation Army General Hospital[NCT02405377] | 264 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ioversol and Kidney Diseases
| Article | Year |
|---|---|
The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Consumer Product Safety; Contrast Media; Evidence-Based Medicine; Female; H | 2009 |
6 trials available for ioversol and Kidney Diseases
| Article | Year |
|---|---|
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.
Topics: Acute-Phase Proteins; Adolescent; Adult; Biomarkers; Child; Chronic Disease; Contrast Media; Cross-S | 2007 |
NGAL is an early predictive biomarker of contrast-induced nephropathy in children.
Topics: Acute-Phase Proteins; Angiography; Biomarkers; Cardiac Catheterization; Child; Contrast Media; Creat | 2007 |
Comparison of the nephrotoxicity between ioversol and iohexol.
Topics: Contrast Media; Female; Humans; Infusions, Intravenous; Iohexol; Kidney; Kidney Diseases; Kidney Fun | 1996 |
[Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial].
Topics: Adult; Aortic Aneurysm, Abdominal; Arteriosclerosis Obliterans; Contrast Media; Double-Blind Method; | 1992 |
[Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Injections, Intravenous; Iopamidol; Ki | 1992 |
[Ioversol 300: clinical study in pediatric intravenous urography].
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Female; Humans; Infant; Injections, Intravenous | 1992 |
16 other studies available for ioversol and Kidney Diseases
| Article | Year |
|---|---|
Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis.
Topics: Animals; Apoptosis; Contrast Media; Kidney Diseases; Lignans; Male; Oxidative Stress; Rats; Rats, Sp | 2014 |
Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Contrast Media; Creatinine; Inflammation; Kidney; Kidney Di | 2015 |
Sulforaphane Attenuates Contrast-Induced Nephropathy in Rats via Nrf2/HO-1 Pathway.
Topics: Animals; Contrast Media; Female; Heme Oxygenase (Decyclizing); Isothiocyanates; Kidney Diseases; Mal | 2016 |
Sulodexide Protects Contrast-Induced Nephropathy in Sprague-Dawley Rats.
Topics: Animals; Antithrombin III; Apoptosis; Blood Urea Nitrogen; Caspase 3; Cell Line; Contrast Media; Cre | 2016 |
Contrast administration in pediatric cardiac catheterization: dose and adverse events.
Topics: Adolescent; Age Factors; Body Weight; Cardiac Catheterization; Child; Child, Preschool; Contrast Med | 2009 |
Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creati | 2009 |
Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Creatinine; Female; Humans; Injections, | 2010 |
Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Humans; Incidence; Kidney Di | 2011 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Dopamine Agonists; Female; Fenoldopam; Humans; Kidne | 2002 |
Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity.
Topics: Adenosine Triphosphate; Animals; Caveolin 1; Caveolins; Cell Line; Cell Membrane; Contrast Media; Cy | 2003 |
A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein.
Topics: Animals; Apoptosis; Bucladesine; Caspases; Cell Survival; Contrast Media; Cyclic AMP Response Elemen | 2005 |
Renal function and cardiac angiography.
Topics: Adolescent; Cardiac Catheterization; Child; Child, Preschool; Contrast Media; Cyanosis; Heart Diseas | 2006 |
Intravenous excretory urography using Optiray in office urology.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Injections, Intravenous; Kidney Dise | 1995 |
Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy.
Topics: Animals; Cattle; Cells, Cultured; Contrast Media; Endothelins; Endothelium, Vascular; In Vitro Techn | 1993 |
Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam.
Topics: Aged; Atherectomy, Coronary; Cardiac Catheterization; Contrast Media; Diabetic Nephropathies; Dopami | 2002 |